UK Fines Pfizer For Missed Deadline In Epilepsy Med Probe
The U.K.'s competition enforcement agency said Tuesday it had fined Pfizer for unreasonably missing a deadline to answer a question as the regulator investigates whether the drugmaker charged illegally excessive prices...To view the full article, register now.
Already a subscriber? Click here to view full article